Skip to main content

Table 9 Univariate and multivariate Cox hazard analyses of the risk factors for survival after diagnosis of cancer

From: Prognosis of incidental pulmonary embolism vs. symptomatic pulmonary embolism in cancer patients: a single-center retrospective cohort study in China

 

Univariate analysis

Multivariate analysis

HR (95% CI)

P-value

HR (95% CI)

P-value

Age ≥ 70 y

1.989 (1.217–3.251)

0.006*

1.909 (1.152–3.162)

0.012*

Female sex

0.857 (0.567–1.296)

0.466

  

Stage IV disease

1.765 (1.015–3.072)

0.044*

1.560 (0.879–2.768)

0.128

SPE

1.823 (1.200–2.768)

0.005*

1.341 (0.852–2.110)

0.205

Central or lobar location

0.775 (0.498–1.206)

0.258

  

Central, lobar, or segmental location

0.902 (0.584–1.393)

0.643

  

Multiple

1.431 (0.760–2.691)

0.267

  

Bilateral

1.142 (0.751–1.738)

0.535

  

Combined with DVT

1.029 (0.684–1.549)

0.891

  

ECOG PS > 1

2.193 (1.436–3.350)

< 0.001*

1.702 (1.071–2.705)

0.025*

Low BMI

1.923 (0.779–4.750)

0.156

  

Overweight

0.557 (0.369–0.841)

0.005*

0.647 (0.425–0.985)

0.042*

Obesity

0.709 (0.386–1.302)

0.267

  

Anticoagulation therapy

20.698 (0.017–24612.726)

0.402

  

Thrombolytic therapy

1.303 (0.470–3.616)

0.611

  

Filter implantation

0.733 (0.320–1.682)

0.464

  

Bleeding event

0.776 (0.399–1.510)

0.456

  
  1. PE, pulmonary embolism; HR, hazard ratio; CI, confidence interval; SPE, symptomatic pulmonary embolism; DVT, deep vein thrombosis; ECOG PS, Eastern Cooperative Oncology Group performance status; BMI, body mass index; * means P < 0.05